I am highly confident the company will survive for two reasons. Conrad has already shown he can raise money in difficult circumstances and The company should start receiving revenues from the current GSA contract this quarter.I also believe both domestic and international sales will increase.
Certainly the JD-MD who was hired still took the job knowing the financial condition of the company. Why would she do that if she thought the company wasn't going to be around?
The risk/reward of this stock is unbelievable! This is a 35 billion dollar industry and we have the most effective, most cost effective and safest product on the market. (we only need 1% market share to make a fortune) Pfizer sells 5 billion of just Lyrica ever year and we get 4 times the efficacy with NO side effects. Lyrica has over 20 known side effects. some of these are life threatening.) Sure there are risks.( Lyrica has more risks than this stock)That's why we are trading at .20 not $10. The risk factor is already reflected in the price. This stock could go up 10 fold on one news release. This stock could go up a 100 fold on an FDA approval. I like the risk vs. reward ratio on this stock at this price at this time.
News 
Market Data 
Discover 
